In vitro and in vivo activities of levofloxacin against biofilm- producing Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1641-1645

  Ishida, Hiroko ^a,b   Ishida, Yoshihisa ^a   Kurosaka, Yuichi ^a   Otani, Tsuyoshi ^a   Sato, Kenichi ^a   Kobayashi, Hiroyuki ^a  

^a KYORIN UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ALGINIC ACID; BUFFER; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL PNEUMONIA; BACTERICIDAL ACTIVITY; BIOFILM; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GUINEA PIG; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031861798     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1641     Document Type: Article

References (35)

1. Anwar, H., M. Dasgupta, K. Lam, and J. W. Costerton. 1989. Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation. J. Biomed. Mater. Res. 25:865-874.
2. Buret, A., K. H. Ward, M. E. Olspn, and J. W. Costerton. 1991. An in vivo model to study the pathobiology of infectious biofilms on biomaterial surfaces. J. Antimicrob. Chemother. 24:647-655.
3. Chu, D. T. W., and P. B. Fernandes. 1989. Structure-activity relationships of the fluoroquinolones. Antimicrob. Agents Chemother. 33:131-135.
4. Chuard, C., J. C. Lucet, P. Rohner, M. Herrmann, R. Auckenthaler, F. A. Waldyogel, and D. P. Lew. 1991. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J. Infect. Dis. 163:1369-1373.
5. Costerton, J. W., and K. J. Cheng. 1981. The bacterial glycocalyx in nature and disease. Annu. Rev. Microbiol. 35:299-324.
6. Evans, D. J., D. G. Alison, M. R. W. Brown, and P. Gilbert. 1991. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms toward ciprofloxacin: effect of specific growth rate. J. Antimicrob. Chemother. 27:177-184.
7. Govan, J. R. W., and J. A. M. Fyfe. 1978. Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid form to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro. J. Antimicrob. Chemother. 4:233-240.
8. Gray, E. D., G. Peter, M. Verstegen, and W. E. Regelmann. 1984. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1:365-367.
9. Gristina, A. G., C. D. Hobgood, L. X. Webb, and Q. N. Myrvik. 1987. Adhesive colonization of biomaterials and antibiotic resistance. Biomaterials 8:423-426.
10. Hoyle, B. D., and J. W. Costerton. 1991. Bacterial resistance to antibiotics: the role of biofilms. Prog. Drug Res. 37:91-105.
11. Ishida, Y., T. Otani, M. Ohashi, K. Someya, K. Yoshida, I. Hayakawa, and Y. Osada. 1993. DU-6859a, a new quinolone: therapeutic efficacy on experimental pneumonia due to Pseudomonas aeruginosa and Streptococcus pneumoniae, abstr. 998, p. 302. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
12. Ishida, Y. 1995. Experimental pneumonia with Pseudomonas aeruginosa in immunosuppressed guinea pigs as a model for biofilm-associated infection. J. Jpn. Assoc. Infect. Dis. 69:572-581.
13. Johnson, G. M., D. A. Lee, W. E. Regelmann, E. D. Gray, G. Peters, and P. G. Quie. 1986. Interference with granulocyte function by Staphylococcus epidermidis slime. Infect. Immun. 54:13-20.
14. Kellenberger, E., A. Ryter, and J. Sechaud. 1958. Electron microscope study of DNA-containing plasms. II. Vegetative and mature phage DNA as compared with normal bacterial nucleoids in different physiological states. J. Biophys. Biochem. Cytol. Mol. Gen. Genet. 4:671-678.
15. Kobayashi, H. 1991. Relationship with host condition and pulmonary infection. J. Jpn. Soc. Intern. Med. 80:663-668. (In Japanese.)
16. LeChevallier, M. W., C. D. Cawthon, and R. G. Lee. 1988. Inactivation of biofilm bacteria. Appl. Environ. Microbiol. 54:2492-2499.
17. Moore, R. D., P. S. Lietman, and C. R. Smith. 1987. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J. Infect. Dis. 155:93-99.
18. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
19. Nichols, W. W., M. J. Evans, M. P. E. Slack, and H. L. Walmsley. 1989. The penetration of antibiotics into aggregates of mucoid and nonmucoid Pseudomonas aeruginosa. J. Gen. Microbiol. 135:1291-1303.
20. Nichols, W. W., S. M. Dorrington, M. P. E. Slack, and H. L. Walmsley. 1988. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob. Agents Chemother. 32:518-523.
21. Ohgaki, N. 1994. Bacterial biofilm in chronic airway infection. J. Jpn. Assoc. Infect. Dis. 68:138-151.
22. Otani, T., K. Katami, T. Une, Y. Osada, and H. Ogawa. 1982. Nonbacteremic Pseudomonas aeruginosa pneumonia in immunosuppressed guinea pigs. Microbiol. Immunol. 26:67-76.
23. Otani, T., R. Nakajima, S. Hashimoto, Y. Iigo, Y. Ishida, T. Une, and Y. Osada. 1989. Chemotherapeutic efficacy of ofloxacin against experimental pneumonia with Pseudomonas aeruginosa in guinea pigs. Arzneim. Forsch. 39:694-697.
24. Pier, G. B. 1985. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. J. Infect. Dis. 151:575-580.
25. Prins, J. M., H. R. Buller, E. J. Kuijper, R. A. Tange, and P. Speelman. 1993. Once versus thrice daily gentamicin in patients with serious infections. Lancet 341:335-339.
26. Reid, G., S. Sharma, K. Advikolanu, C. Tieszer, R. A. Martin, and A. W. Bruce. 1994. Effects of ciprofloxacin, norfloxacin, and ofloxacin on in vitro adhesion and survival of Pseudomonas aeruginosa AK1 on urinary catheters. Antimicrob. Agents Chemother. 38:1490-1495.
27. Rosen, T. 1990. The fluoroquinolone antibacterial agents. Prog. Med. Chem. 27:235-295.
28. Shigeta, M. G. Tanaka, H. Komatsuzawa, M. Sugai, H. Sugmaka, and T. Usui. 1997. Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. Chemotherapy (Basel) 43:340-345.
29. Soboh, F., A. E. Khoury, A. C. Zamboni, D. Davidson, and M. W. Mittelman. 1995. Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 39:1281-1286.
30. Stewart, P. S. 1994. Biofilm accumulation model that predicts antibiotic resistance of Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 38:1052-1058.
31. Tanaka M., M. Otsuki, and T. Nishino. 1992. Bactericidal activities of ofloxacin and its optically active isomer (DR-3355) on non-growing cells of Escherichia coli and Pseudomonas aeruginosa. Chemotherapy (Basel) 38:21-27.
32. Vaudaux, P. E., G. Zulian, E. Huggler, and F. A. Waldvogel. 1985. Attachment of Staphylococcus aureus to polymethyl-methacrylate increases its resistance to phagocytosis in foreign body infection. Infect. Immun. 50:472-477.
33. Vrany, J. D., P. S. Stewart, and P. A. Suci. 1997. Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa biofilms displaying rapid-transport characteristics. Antimicrob. Agents Chemother. 41:1352-1358.
34. Wright, J. B., I. Ruseska, M. A. Athar, S. Corbett, and J. W. Costerton. 1989. Legionella pneumophila grows adherent to surfaces in vitro and in situ. Infect. Control Hosp. Epidemiol. 10:408-415.
35. Yassien, M., N. Khardori, A. Ahmedy, and M. Toama. 1995. Modulation of biofilms of Pseudomonas aeruginosa by quinolones. Antimicrob. Agents Chemother. 39:2262-2268.